drugset / Trial / NCT02534753
A Pharmacokinetics Study of Intravenous Ascorbic Acid
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, single-dose study to evaluate the pharmacokinetics of intravenous Ascorbic Acid.
Timeline
- Start
- 2015-09
- Primary completion
- 2015-11
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin C | Other / unclassified | 500 mg/ml | Intravenous |
Indications
No indication recorded.